BioSpace Movers & Shakers, Nov. 6
The Pharma Data
NOVEMBER 5, 2020
has been appointed to the additional role of president and will oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke. Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. from 1993 to 1995.
Let's personalize your content